Search clinical trials for: lapatinib
Total 1440 results
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Kansas Medical CenterGlaxoSmithKline; NovartisUnknownMetastatic Breast CancerUnited States
-
Guangxi Medical UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHepatocellular Carcinoma Resectable
-
Tianjin Medical University Second HospitalUnknownSmall Cell Lung Cancer Extensive StageChina
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International HospitalWithdrawnAdvanced Cancer | Soft Tissue Sarcoma AdultChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationChina
-
HRYZ Biotech Co.Recruiting
-
Elevar TherapeuticsCompleted
-
Peking University Cancer Hospital & InstituteUnknown
-
GlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
Centre Jean PerrinTerminatedColorectal Cancer | Metastatic Breast CancerFrance
-
Hyoung Jin KangNot yet recruitingAcute Lymphoblastic Leukemia, Pediatric
-
Shanghai Zhongshan HospitalRecruitingHepatocellular Carcinoma | Immunotherapy | Molecular Targeted TherapyChina
-
Beijing Friendship HospitalCompletedCamrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.Biliary Tract Cancer | Capecitabine | Targeted Molecular Therapy | Anti-PD-1 TherapyChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceutical Co., Ltd.UnknownHepatocellular CarcinomaChina
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.CompletedNasopharyngeal NeoplasmsChina
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital of LingshanCompletedNasopharyngeal CarcinomaChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityJiangsu HengRui Medicine Co., Ltd.UnknownLocally Advanced Gastric CancerChina
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Fudan UniversityNot yet recruiting
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
Yan LiJiangsu HengRui Medicine Co., Ltd.Unknown
-
Hebei Medical University Fourth HospitalUnknownRefractory or Metastatic Esophageal Squamous Cell CarcinomaChina
-
Chinese PLA General HospitalUnknown
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastRussian Federation, China, Brazil, Hong Kong, Pakistan, Peru, Thailand, Ukraine
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedHER-2 Positive Breast Cancer | Malignant Neoplasm of BreastItaly
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Taiwan University HospitalGlaxoSmithKlineCompletedMetastatic Breast CancerTaiwan
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.TerminatedBreast CancerUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastBelgium, United States
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
-
GlaxoSmithKlineCompletedNeoplasms, BreastPoland, Russian Federation, Latvia, Romania
-
Peking Union Medical College HospitalRecruitingRadioactive Iodine-refractory Differentiated Thyroid CancerChina
-
Sun Yat-sen UniversityNot yet recruiting
-
Beijing Friendship HospitalUnknown
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International HospitalCompletedEfficacy | ToxicityChina
-
National Cancer Institute (NCI)NRG OncologyTerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States
-
Xspray Pharma ABQPS Bioserve India Pvt LimitedCompleted
-
Institute of Cancer Research, United KingdomNovartis; Cancer Research UK; Manchester University NHS Foundation Trust; University...Active, not recruitingBreast CancerUnited Kingdom
-
DongMaUnknownAdvanced Gastric CancerChina
-
Sun Yat-sen UniversityNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingNeoplasm Malignant | Tumor, Solid | Cancer, MetastaticChina
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedMetastatic Pancreatic CancerUnited States
-
Washington University School of MedicineWithdrawn
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed